Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bio-Rad Laboratories, Inc. BIO

Set alert

Price alert · BIO

All alert types
372.99 USD +6.83 +1.87%

As of Nov 3, 3:12 PM ET

Bid
372.50 × 1
Ask
373.29 × 1
369.86 Day range 376.81
241.71 52-week range 390.34
YTD
+23.10%
1 year
+19.77%
Open
369.45
Prev close
366.16
Mkt cap
9.99B
Vol
113.58K
Avg vol
254.03K
EPS
7.89
P/E
47.34
Div yield
0.00%
More statistics
Low
369.86
High
376.81
Forward P/E
37.57
Beta
1.06
Short ratio
4.17
Inst. own
91.74%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
374.80
200-d avg
313.41
1y target
335.00

30m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (13)
NameTimeAgo
SMA: BullishNov 3, 9:55 AM5 hours ago
SMA: BullishNov 3, 9:55 AM5 hours ago
MACD: Buy SignalNov 3, 9:55 AM5 hours ago
RSI: OversoldNov 2, 2:25 PM1 day ago
MACD: Sell SignalNov 2, 1:55 PM1 day ago
SMA: BearishNov 2, 11:55 AM1 day ago
SMA: BullishNov 2, 11:25 AM1 day ago
SMA: BearishNov 2, 10:55 AM1 day ago
MACD: Buy SignalNov 2, 10:25 AM1 day ago
SMA: BullishOct 30, 3:25 PM4 days ago
RSI: OversoldOct 30, 10:25 AM4 days ago
SMA: BearishOct 29, 1:25 PM5 days ago
SMA: BullishOct 28, 2:55 PM6 days ago

Analyst view

Consensus: hold

Hold
Price target (mean) 335.00 -10.2% downside
Target (low)
280.00
Target (mean)
335.00
Target (high)
390.00
Ratings (0m) 3 1 buy · 1 hold · 1 sell
  • Strong buy1
  • Buy0
  • Hold1
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.232.16 – 2.292.26-1.6%649.95M-0.5%2
Next quarter3.022.74 – 3.302.51+20.3%695.40M+0.3%2
Current year9.458.85 – 10.109.92-4.7%2.57B-0.5%3
Next year9.758.75 – 10.909.45+3.1%2.62B+2.1%3

Upgrades and downgrades

The latest rating changes

BIO analyst upgrades and downgrades
DateFirmActionFromTo
Aug 7, 2026RBC CapitalMaintainedOutperformOutperform
Aug 5, 2026CitigroupMaintainedNeutralNeutral
Aug 5, 2026RBC CapitalMaintainedOutperformOutperform
Aug 5, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
May 1, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Apr 7, 2026CitigroupDowngradeBuyNeutral
Feb 16, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 30, 2025CitigroupMaintainedBuyBuy
Oct 30, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 1, 2025RBC CapitalMaintainedOutperformOutperform
Aug 1, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Jun 9, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
May 2, 2025UBSMaintainedBuyBuy
May 2, 2025CitigroupMaintainedBuyBuy
May 2, 2025RBC CapitalMaintainedOutperformOutperform
Apr 17, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Feb 12, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Jan 14, 2025RBC CapitalReiteratedOutperformOutperform
Dec 9, 2024RBC CapitalMaintainedOutperformOutperform
Oct 31, 2024CitigroupMaintainedBuyBuy
Oct 31, 2024RBC CapitalMaintainedOutperformOutperform
Oct 1, 2024CitigroupUpgradeNeutralBuy
Aug 27, 2024Wells FargoInitiated—Equal-Weight
Aug 16, 2024RBC CapitalReiteratedOutperformOutperform
Aug 2, 2024RBC CapitalMaintainedOutperformOutperform
Aug 2, 2024CitigroupMaintainedNeutralNeutral
May 8, 2024UBSMaintainedBuyBuy
Apr 3, 2024CitigroupDowngradeBuyNeutral
Feb 16, 2024UBSMaintainedBuyBuy
Feb 16, 2024RBC CapitalMaintainedOutperformOutperform